Nearly 1,000 patients with coronavirus in the UK have enrolled in the world’s largest randomized clinical trial of potential COVID-19 treatments. The trial, which has been prioritized and fast-tracked by the UK government, will examine the value of HIV, anti-inflammatory and anti-malarial drugs in fighting the virus. Read More

A number of research efforts reported disruptions last week to their trial efforts due to the COVID-19 pandemic: Read More

Sponsors and investigators conducting federally funded research do not need IRB approval for actions taken in response to the threat of COVID-19 as long as those actions are for public health or clinical treatments purposes rather than research, according to a new guidance from the Office for Human Research Protections (OHRP). Read More

Researchers planning trials on the use of convalescent blood plasma to treat COVID-19 must submit an investigational new drug (IND) application, according to a new FDA final guidance that will remain in effect only for the duration of the public health emergency. Read More

COVID-19 Drug Research Roundup Read More

Applications for clinical trials in Belgium can now receive the go-ahead from the government within four days rather than the two to four weeks sponsors previously had to wait. Read More

While some sponsors are pulling back on enrollment and site activation, others are expressing confidence that they can continue their trial activities with adjustments to avoid the risk of COVID-19 exposure. Read More

WCG Clinical has launched a new COVID-19 online patient resource center to help trial participants understand how the pandemic may affect their trials and to help prospective participants match to clinical trials via CenterWatch iConnect. Read More